Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Melanoma

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

October 2009
1. BOARD RE , Ellison G, Orr MC, Kemsley KR, et al
   Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
2. FLOCKHART RJ , Armstrong JL, Reynolds NJ, Lovat PE, et al
   NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   August 2009
3. BAUER J , Kilic E, Vaarwater J, Bastian BC, et al
   Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
4. MUELLER DW , Bosserhoff AK
   Role of miRNAs in the progression of malignant melanoma.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. BEUSTERIEN KM , Szabo SM, Kotapati S, Mukherjee J, et al
   Societal preference values for advanced melanoma health states in the United Kingdom and Australia.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   June 2009
6. MAAT W , Filali ME, Mulder AD, Luyten GP, et al
   Episodic Src activation in uveal melanoma revealed by kinase activity profiling.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   April 2009
7. SINGH S , Nannuru KC, Sadanandam A, Varney ML, et al
   CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.
   Br J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. WATSON AJ , Middleton MR, McGown G, Thorncroft M, et al
   O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
   Br J Cancer. 2009;100:1250-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. KEFFORD RF , Thomas NP, Corrie PG, Palmer C, et al
   A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
   Br J Cancer. 2009;100:1245-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2009
10. SMALLEY KS , Flaherty KT
    Integrating BRAF/MEK inhibitors into combination therapy for melanoma.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ROCCA A , Minucci S, Tosti G, Croci D, et al
    A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.
    Br J Cancer. 2009;100:28-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. CANTWELL MM , Murray LJ, Catney D, Donnelly D, et al
    Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland.
    Br J Cancer. 2009;100:174-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. NAUMANN SC , Roos WP, Jost E, Belohlavek C, et al
    Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
14. JENSEN A , Thomsen HF, Engebjerg MC, Olesen AB, et al
    Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. SATZGER I , Schaefer T, Kuettler U, Broecker V, et al
    Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. JANSSEN CS , Sibbett R, Henriquez FL, McKay IC, et al
    The T1799A point mutation is present in posterior uveal melanoma.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. JENSEN AO , Thomsen HF, Engebjerg MC, Olesen AB, et al
    Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study.
    Br J Cancer. 2008;99:1522-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
18. DAVIES MA , Stemke-Hale K, Tellez C, Calderone TL, et al
    A novel AKT3 mutation in melanoma tumours and cell lines.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. OTTENSMEIER CH , Gore M
    Survival from melanoma of the skin in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S50-2.
    PubMed     Text format     Related articles   
    
    
    
20. RACHET B , Quinn MJ, Cooper N, Coleman MP, et al
    Survival from melanoma of the skin in England and Wales up to 2001.
    Br J Cancer. 2008;99 Suppl 1:S47-9.
    PubMed     Text format     Related articles   
    
    
    
21. FENS MH , Hill KJ, Issa J, Ashton SE, et al
    Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
    Br J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. KIM KB , Eton O, Davis DW, Frazier ML, et al
    Phase II trial of imatinib mesylate in patients with metastatic melanoma.
    Br J Cancer. 2008;99:734-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
23. ZHANG H , Bermejo JL, Sundquist J, Hemminki K, et al
    Modification of second cancer risk after malignant melanoma by parental history of cancer.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. LESUEUR F , de Lichy M, Barrois M, Durand G, et al
    The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
25. GAMBAROTA G , Leenders W, Maass C, Wesseling P, et al
    Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
    Br J Cancer. 2008;98:1784-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
26. GUGGENHEIM M , Dummer R, Jung FJ, Mihic-Probst D, et al
    The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma - a retrospective analysis of 392 cases.
    Br J Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
27. SHARMA R , Kacevska M, London R, Clarke SJ, et al
    Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
    Br J Cancer. 2008;98:91-7.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: